Everything we publish comes from the same research pipeline as our YouTube channel: real intake tests, cross-checked reviews, and the math the landing pages don't show you.
Compounded semaglutide from $199 the first month, held flat at every dose level, with a physician choosing the molecule instead of your budget. The catch is the other decision: a year paid monthly is $3,488 against $2,148 prepaid.
Compounded semaglutide from $149 a month, held flat at every dose level through the whole titration, and nothing charged to your card until a licensed physician actually prescribes. The month-four bill shock, removed.
A physician-guided oral GLP-1 from $199 a month, with nothing to inject: glycine and B vitamins to protect muscle, a 3D body scan every week, and a refund if you don't lose 10% in six months.
Protein targets, muscle monitoring, exit strategy on day one: what European clinics do that US express prescriptions skip, and the five questions that tell you which model you're buying.
Semaglutide care from $99 and tirzepatide from $149, medication fulfillment included instead of billed separately. Against a $347 cash-pay average, that gap needs explaining, so we went looking for what was removed.
Every charge that never makes the headline, how a $249/month program becomes $550, and the six legal levers that take it back under $300.
Stronger than Ozempic? How much in 3 months? Why are you still hungry? Every answer, plus the microdosing maintenance strategy nobody talks about.
$168 a month that stays the same when your dose goes up, needle-free oral GLP-1+GIP, LegitScript pharmacies. The pricing model holds up; the success statistics need reading carefully.
Dual GLP-1 and GIP action in calibrated progressive doses, same-day doctor consultations, and pharmacy testing standards the company actually publishes. The newest platform we've reviewed.
Ranked on what's inside the price instead of the price itself: muscle loss, follow-up depth, guarantees that match their terms, plus the Medicare rule that beats every cash price on the list.
500,000+ patients, free dietician visits, 24/7 support and a money-back guarantee in one portal, with the compounding-regulation caveat stated plainly.
Real Wegovy, excellent app, and a membership fee billed separately from the medication. The two-charge bill, the 12-month total and the 48-hour cancellation trap, with no affiliate link in sight.
Formulary tiers, pharmacy benefit managers, the five real denial reasons, insurer-by-insurer rules and the new Medicare GLP-1 Bridge at $50/month.
One flat monthly price, everything included, no membership or lab fees: the GLP-1 program where the price you see is the price you pay.
Weekly body scans, muscle-preservation supplements and a 24/7 in-app doctor: why Hume Care Plus is our #1 telehealth weight loss program for 2026.
First month from $49, a same-price-at-every-dose guarantee and labs included: the lowest cost of entry into serious GLP-1 therapy.
Flat pricing that doesn't jump at the maintenance dose, consultation included, and real humans in support: zero surprises by design.
Semaglutide from $199/mo, tirzepatide from $299/mo, needle-free formats and a 5%-in-120-days money-back guarantee, now with the full video review.
Fast video visits with board-certified dermatologists at flat cash prices, prescription skincare from $59/month, no insurance needed.
Birth control and UTI visits at $45, menopause and PCOS care at $59/month with labs included: accessible women's health, reviewed.
Video visits from $35, GLP-1 access from $59/month, 383 services and a million patients served: the cash-price marketplace, reviewed.
Semaglutide from $49 first month and $88/month ongoing: the current best deals, verified platform by platform, updated every week.
Manufacturer savings cards, 503B compounded options, patient assistance programs: every legal strategy to cut your monthly cost.
All 8 ranked offers are now reviewed
New reviews and weekly price updates land here first, and every article starts as a video on the TeleHealthRanks channel. Subscribe to catch them early.